Princeton University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Princeton University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014172
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Princeton University (Princeton) is a research university that provides undergraduate and graduate instruction. The university offer education in the areas of humanities, social sciences, natural sciences and engineering. It provides services such as health services, event planning, external affairs, information technology, safety and preparedness, transportation and parking, business systems, finance and purchasing, and legal policies. Princeton operates with academic departments and centers. It offers interdisciplinary undergraduate certificate programs. The university also offers scholarship and master’s degree programs in architecture, engineering, finance, and public affairs, among others. Princeton is headquartered in Princeton, New Jersey, the US.

Princeton University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Princeton University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Princeton University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Princeton University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Princeton University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Princeton University, Medical Devices Deals, 2011 to YTD 2017 9
Princeton University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Princeton University, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 11
Partnerships 12
Nevakar Enters into Research Agreement with Princeton University 12
Bristol-Myers Squibb Enters into Research Agreement with Princeton University 13
Thermo Fisher Enters Into An Agreement With Princeton University 14
Licensing Agreements 15
Forge Life Science Enters into Licensing Agreement with Princeton University 15
Princeton University – Key Competitors 16
Princeton University – Key Employees 17
Princeton University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
May 22, 2017: New Jersey Health Foundation Awards $50,000 Innovation Grant To Princeton University Researchers Studying Metastatic Cancer Cells 19
May 22, 2017: Study identifies RNA molecule that shields breast cancer stem cells from immune system 20
Oct 27, 2016: New Jersey Health Foundation Awards $50,000 Innovation Grant To Princeton University Researcher Working to Manipulate Cellular DNA for Improved Disease Treatments 21
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 22
Sep 06, 2016: New Jersey Health Foundation Commits $1 Million To Fund Latest Cycle of Research Grants Program 24
Feb 18, 2016: Ebola crisis provides framework for responding to outbreaks like Zika virus 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Princeton University, Pharmaceuticals & Healthcare, Key Facts 2
Princeton University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Princeton University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Princeton University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Princeton University, Deals By Therapy Area, 2011 to YTD 2017 8
Princeton University, Medical Devices Deals, 2011 to YTD 2017 9
Princeton University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 11
Nevakar Enters into Research Agreement with Princeton University 12
Bristol-Myers Squibb Enters into Research Agreement with Princeton University 13
Thermo Fisher Enters Into An Agreement With Princeton University 14
Forge Life Science Enters into Licensing Agreement with Princeton University 15
Princeton University, Key Competitors 16
Princeton University, Key Employees 17
Princeton University, Subsidiaries 18

★海外企業調査レポート[Princeton University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ADOBE Inc (ADBE):企業の財務・戦略的SWOT分析
    ADOBE Inc (ADBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Canadian Energy Services & Technology Corp. (CEU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Energy Services & Technology Corp (CES) is a provider of chemical solutions. It provides technically advanced consumable chemical solutions for the North American oil and gas industry. The total solution provided by the company includes the drill-bit, at the point of completion and …
  • Cub Energy Inc (KUB):石油・ガス:M&Aディール及び事業提携情報
    Summary Cub Energy Inc (Cub Energy), formerly 3P International Energy Corp is an oil and gas company that explores and develops oil and gas assets in Ukraine. The company operates its oil and gas exploration assets in Transcarpathian Basin and Dnieper-Donets Basin. It uses technologies such as fract …
  • Fuji Seal International Inc.:戦略・SWOT・企業財務分析
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Toleranzia AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Toleranzia AB (Toleranzia) is a drug developer that utilizes immune system’s intrinsic power to treat autoimmune diseases. The company offers products and technologies including Re-Tolerogen for the treatment of autoimmune diseases. Its Re-Tolerogen platform technology is a fusion protein fo …
  • Les Laboratoires Servier SAS:企業の戦略的SWOT分析
    Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Iberdrola SA (IBE):企業の財務・戦略的SWOT分析
    Iberdrola SA (IBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • New Look Retail Group Limited:企業の戦略・SWOT・財務情報
    New Look Retail Group Limited - Strategy, SWOT and Corporate Finance Report Summary New Look Retail Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, …
  • Atopix Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • Bracket Global LLC-製薬・医療分野:企業M&A・提携分析
    Summary Bracket Global LLC (Bracket Global) is pharmaceutical company that offers clinical research development services. It strives to bring together science, technology and service to provide superior clinical outcomes for pharmaceutical companies and patients. The company offers services such as …
  • The Advisory Board Company:企業の戦略的SWOT分析
    The Advisory Board Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Biomatrica Inc-医療機器分野:企業M&A・提携分析
    Summary Biomatrica Inc (Biomatrica) is a biological stabilization products developer that offers healthcare technology products. The company offers assay design and use; omics sample collection, and transport and storage chemistry products. Its transport and storage chemistry products comprise custo …
  • Vodafone Group Plc:企業の戦略・SWOT・財務情報
    Vodafone Group Plc - Strategy, SWOT and Corporate Finance Report Summary Vodafone Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monova …
  • BioStar Pharmaceuticals Inc (BSPM):企業の財務・戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • First Republic Bank:企業のM&A・事業提携・投資動向
    First Republic Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Republic Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Porton Fine Chemicals Ltd (300363):製薬・医療:M&Aディール及び事業提携情報
    Summary Porton Fine Chemicals Ltd (Porton) is a supplier of custom drug intermediates and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It provides products such as reactive reagents, chiral chromatography produ …
  • Bahrain Telecommunications Company BSC (BATELCO):企業の戦略的SWOT分析
    Bahrain Telecommunications Company BSC (BATELCO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Toyo Seikan Group Holdings, Ltd.:企業の戦略・SWOT・財務情報
    Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆